Prendo (SymptoLab)

A digital health platform that helps women with hormone-related conditions track and predict symptom fluctuations over time.

Healthcare & Life Sciences
Active
New York City, United States Founded 2024
Last updated 2026-09-01
Total raised
—
Stage
—
Founded
2024
Headcount
6
HQ
New York City, United States
Sector
Healthcare & Life Sciences

About

SymptoLab is a digital health company that provides an AI-powered clinical decision-support platform to help physicians and patients manage complex, hormone-driven conditions. It converts daily symptom tracking into clear, personalized insights, aiming to help patients regain control of pain, provide clinicians with decision support for treatment planning, and lower healthcare costs. The platform uses advanced analytics and machine learning to transform real-world symptom data into actionable medical insights, initially focusing on endometriosis, with plans to expand to other hormone-related conditions like fertility, adenomyosis, fibroids, PCOS, fibromyalgia, neuropathy, and pre-menopausal conditions. SymptoLab emphasizes a privacy-first approach, ensuring user control over data and only using de-identified, aggregated data to advance women’s health research and improve analytics.

Headcount over time

6 employees (2026-09) · 1 point
6 6 2026-09

Offices

New York City, United States · HQ / main office

Q&A

What is Prendo (SymptoLab)'s primary focus?
Prendo (SymptoLab) is a digital health platform that helps women with hormone-related conditions track and predict symptom fluctuations over time.
When was Prendo (SymptoLab) founded?
Prendo (SymptoLab) was founded in 2024.
Where is Prendo (SymptoLab) headquartered?
Prendo (SymptoLab) is headquartered in New York City, United States.
Who are the co-founders of Prendo (SymptoLab)?
The co-founders of Prendo (SymptoLab) are Tamar Zelovich-Hod and Alon Zelovich, both appointed in 2025.
What technologies does Prendo (SymptoLab) utilize?
Prendo (SymptoLab) utilizes mathematical modeling, machine learning, and advanced analytics.
What types of customers does Prendo (SymptoLab) target?
Prendo (SymptoLab) targets patients, physicians, and health plans.
What is the role of Vered Klaitman-Meyer at Prendo (SymptoLab)?
Vered Klaitman-Meyer serves as the Medical Director of Gynecology at Prendo (SymptoLab).
What is the core technology behind Prendo (SymptoLab)'s platform?
The core technology behind Prendo (SymptoLab)'s platform is an AI-powered platform.

Team · 6

Tamar Zelovich, PhD
Founder · CEO
Alon Zelovich
Founder · CTO
Noemie Elhadad, PhD
Head of Advisory Board
Vered Klaitman-Meyer, MD
Board Member
Michael Lewis, MD
Board Member
Taraneh Shirazian, MD
Board Member

Sectors & technology

Primary sector
Healthcare & Life Sciences
Technologies
Target customers
Business model
B2B2CSubscription SaaSServices & Consulting
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesymptolab.com

Identifiers & details

Founded2024
Employees (exact)6

Radar intelligence

Web history (Wayback)

Domainsymptolab.com

Certificate / subdomain footprint

Subdomains8